Company profile for Chroma Medicine

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Chroma Medicine is pioneering a new class of single-dose genomic medicines that harness epigenetics, nature’s innate mechanism for gene regulation, revolutionizing the treatment of disease. Epigenetics is nature’s central mechanism for gene regulation, governing cell phenotype and function by precisely controlling gene activity without changing the underlying DNA sequence. Building on groundbreaking research from the wo...
Chroma Medicine is pioneering a new class of single-dose genomic medicines that harness epigenetics, nature’s innate mechanism for gene regulation, revolutionizing the treatment of disease. Epigenetics is nature’s central mechanism for gene regulation, governing cell phenotype and function by precisely controlling gene activity without changing the underlying DNA sequence. Building on groundbreaking research from the world’s foremost genomic medicine experts, Chroma Medicine is working at the cutting edge of precision genomics, building an entirely new class of therapeutics to achieve unparalleled control of gene expression.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
201 Brookline Ave Suite 1101 Boston, MA 02215
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/chroma-medicine-presents-preclinical-in-vivo-data-demonstrating-best-in-class-potency-and-durable-cholesterol-reduction-with-a-pcsk9-targeted-epigenetic-editor-at-the-2024-esc-congress-302235320.html

PR NEWSWIRE
03 Sep 2024

https://endpts.com/epigenetic-editing-startup-chroma-lays-off-staff-focusing-on-reaching-the-clinic/

ENDPTS
01 May 2024

https://www.prnewswire.com/news-releases/chroma-medicine-presents-preclinical-in-vivo-data-showing-durable-cholesterol-reduction-with-a-pcsk9-targeted-epigenetic-editor-at-the-2023-aha-scientific-sessions-301985074.html

PR NEWSWIRE
11 Nov 2023

https://www.prnewswire.com/news-releases/chroma-medicine-presents-data-showing-specific-and-durable-hbv-silencing-with-epigenetic-editors-at-the-hbv-international-meeting-2023-301932782.html

PR NEWSWIRE
20 Sep 2023

https://www.businesswire.com/news/home/20230719123616/en

BUSINESSWIRE
20 Jul 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty